FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Karl Nicholson

Research Profile

Disorders

Chemicals & Drugs

Procedures

Living Beings

Geographic Areas

Phenomena

Disease Outbreaks

Concepts & Ideas

Time Factors

Co-author Network

Publications

TOP 3
Puja Myles; Jonathan Nguyen Van-Tam; Karl G Nicholson; Peter J Openshaw; Robert C Read; Malcolm G Semple; Bruce L Taylor; Barbara Bannister; Stephen J Brett; Joanne E Enstone; Wei Shen Lim; Jim McMenamin
Differences between asthmatics and nonasthmatics hospitalised with influenza A infection.
Puja R Myles; Jonathan Nguyen Van-Tam; Karl G Nicholson; Peter J M Openshaw; Robert C Read; Barbara Bannister; Stephen J Brett; Joanne E Enstone; Wei Shen Lim; James McMenamin; Bruce L Taylor; Malcolm G Semple
Comparison of CATs, CURB-65 and PMEWS as triage tools in pandemic influenza admissions to UK hospitals: case control analysis using retrospective data.
Mona Bafadhel; Michael R Barer; Sally Batham; Tristan W Clark; Marie-jo Medina; Karl G Nicholson; Carlene Reid; Christopher E Brightling
Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Karl Nicholson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Puja Myles; Jonathan Nguyen Van-Tam; Karl G Nicholson; Peter J Openshaw; Robert C Read; Malcolm G Semple; Bruce L Taylor; Barbara Bannister; Stephen J Brett; Joanne E Enstone; Wei Shen Lim; Jim McMenamin
Differences between asthmatics and nonasthmatics hospitalised with influenza A infection.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2013;41(4):824-31.
2012: Puja R Myles; Jonathan Nguyen Van-Tam; Karl G Nicholson; Peter J M Openshaw; Robert C Read; Barbara Bannister; Stephen J Brett; Joanne E Enstone; Wei Shen Lim; James McMenamin; Bruce L Taylor; Malcolm G Semple
Comparison of CATs, CURB-65 and PMEWS as triage tools in pandemic influenza admissions to UK hospitals: case control analysis using retrospective data.
PloS one 2012;7(4):e34428.
2011: Mona Bafadhel; Michael R Barer; Sally Batham; Tristan W Clark; Marie-jo Medina; Karl G Nicholson; Carlene Reid; Christopher E Brightling
Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD.
Chest 2011;139(6):1410-8.
2011: Joanne E Enstone; Puja R Myles; Peter J M Openshaw; Elaine M Gadd; Wei Shen Lim; Malcolm G Semple; Robert C Read; Bruce L Taylor; James McMenamin; Colin Armstrong; Barbara Bannister; Karl G Nicholson; Jonathan Nguyen Van-Tam
Nosocomial pandemic (H1N1) 2009, United Kingdom, 2009-2010.
Emerging infectious diseases 2011;17(4):592-8.
2011: Rachel J Jackson; Katy Cooper; Paul Tappenden; Angie Rees; Emma Simpson; Robert C Read; Karl G Nicholson
Oseltamivir, zanamivir and amantadine in the prevention of influenza: a systematic review.
The Journal of infection 2011;62(1):14-25.
2010: R L Puleston; G Bugg; K Hoschler; J Konje; James thornton; Iain Stephenson; P Myles; J Enstone; G Augustine; Y Davis; Maria C Zambon; Karl G Nicholson; Jonathan Nguyen Van-Tam
Observational study to investigate vertically acquired passive immunity in babies of mothers vaccinated against H1N1v during pregnancy.
Health technology assessment (Winchester, England) 2010;14(55):1-82.
2009: Tristan W Clark; Manish Pareek; Katja Hoschler; Helen Dillon; Karl G Nicholson; Nicola Groth; Iain Stephenson
Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.
The New England journal of medicine 2009;361(25):2424-35.
2009: Karl G Nicholson; Catherine I Thompson; Jaco M Klap; John M Wood; Sally Batham; Robert W Newman; Robert Mischler; Maria C Zambon; Iain Stephenson
Safety and immunogenicity of whole-virus, alum-adjuvanted whole-virus, virosomal, and whole-virus intradermal influenza A/H9N2 vaccine formulations.
Vaccine 2009;28(1):171-8.
2009: Jane Burch; M Paulden; S Conti; C Stock; M Corbett; N J Welton; tony ades; Alex Sutton; Nicola Cooper; A J Elliot; Karl G Nicholson; Stephen W Duffy; C McKenna; L Stewart; Marie Westwood; Stephen Palmer
Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation.
Health technology assessment (Winchester, England) 2009;13(58):1-265, iii-iv.
2009: Jane Burch; Mark Corbett; Christian Stock; Karl G Nicholson; Alex J Elliot; Steven Duffy; Marie Westwood; Stephen Palmer; Lesley Stewart
Prescription of anti-influenza drugs for healthy adults: a systematic review and meta-analysis.
The Lancet infectious diseases 2009;9(9):537-45.
2009: Jean-Pierre Michel; Christian Chidiac; Beatrix Grubeck-Loebenstein; Robert W Johnson; Paul Henri Lambert; Stefania Maggi; Robert Moulias; Karl G Nicholson; Hans Werner
Coalition of advocates to vaccinate of Western European citizens aged 60 years and older.
Aging clinical and experimental research 2009;21(3):254-7.
2009: Grazia Galli; Kathy Hancock; Katja Hoschler; Joshua DeVos; Michaela Praus; Monia Bardelli; Carmine Malzone; Flora Castellino; Chiara Gentile; Teresa McNally; Giuseppe Del Giudice; Angelika Banzhoff; V F H Brauer; Emanuele Montomoli; Maria Zambon; Jacqueline Katz; Karl G Nicholson; Iain Stephenson
Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(19):7962-7.
2009: Jean-Pierre Michel; Christian Chidiac; Beatrix Grubeck-Loebenstein; Robert W Johnson; Paul Henri Lambert; Stefania Maggi; Robert Moulias; Karl G Nicholson; Hans Werner
Advocating vaccination of adults aged 60 years and older in Western Europe: statement by the Joint Vaccine Working Group of the European Union Geriatric Medicine Society and the International Association of Gerontology and Geriatrics-European Region.
Rejuvenation research 2009;12(2):127-35.
2009: Karl G Nicholson
Influenza and vaccine development: a continued battle.
Expert review of vaccines 2009;8(4):373-4.
2009: Iain Stephenson; Jane Democratis; Angie Lackenby; Teresa McNally; James Smith; Manish Pareek; Joanna Ellis; Alison Bermingham; Karl G Nicholson; Maria Zambon
Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(4):389-96.
2009: Paul Tappenden; R Jackson; Katy Cooper; Anne Rees; Emma Simpson; R Read; Karl G Nicholson
Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation.
Health technology assessment (Winchester, England) 2009;13(11):iii, ix-xii, 1-246.
2008: Iain Stephenson; Karl G Nicholson; Katja Hoschler; Maria C Zambon; Kathy Hancock; Joshua DeVos; Jacqueline M Katz; Michaela Praus; Angelika Banzhoff
Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1.
The New England journal of medicine 2008;359(15):1631-3.
2008: Lance Jennings; Arnold S Monto; Paul K S Chan; Thomas D Szucs; Karl G Nicholson
Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans.
The Lancet infectious diseases 2008;8(10):650-8.
2008: Patrick T Kimmitt; Andrew Kirby; Nelun Perera; Karl G Nicholson; Paul C Schober; Kumar Rajakumar; Cordelia A Chapman
Identification of Neisseria gonorrhoeae as the causative agent in a case of culture-negative dermatitis-arthritis syndrome using real-time PCR.
Journal of travel medicine 2008;15(5):369-71.
2008: Allan Wailoo; Alex J Sutton; Nicola J Cooper; David A Turner; Keith Abrams; Alan Brennan; Karl G Nicholson
Cost-effectiveness and value of information analyses of neuraminidase inhibitors for the treatment of influenza.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2008;11(2):160-71.
2006: Ganapathy Dhanasekar; Alisdair Robertson; Karl G Nicholson
Atypical presentation of HIV in a pregnant patient.
The Ulster medical journal 2006;75(2):160-1.
2006: Iain Stephenson; Maria C Zambon; Anna Rudin; Anthony Colegate; Audino Podda; Roberto Bugarini; Giuseppe Del Giudice; Ada Minutello; Susan Bonnington; Jan Holmgren; Kingston H G Mills; Karl G Nicholson
Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers.
Journal of virology 2006;80(10):4962-70.
2006: David A Turner; Allan Wailoo; Nicola J Cooper; Alex J Sutton; Keith Abrams; Karl G Nicholson
The cost-effectiveness of influenza vaccination of healthy adults 50-64 years of age.
Vaccine 2006;24(7):1035-43.
2006: Karl G Nicholson; Teresa McNally; Michael Silverman; Paul Simons; Joanne D Stockton; Maria C Zambon
Rates of hospitalisation for influenza, respiratory syncytial virus and human metapneumovirus among infants and young children.
Vaccine 2006;24(1):102-8.
2005: Iain Stephenson; Roberto Bugarini; Karl G Nicholson; Audino Podda; John M Wood; Maria C Zambon; Jacqueline M Katz
Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.
The Journal of infectious diseases 2005;191(8):1210-5.
2004: Iain Stephenson; Karl G Nicholson; John M Wood; Maria C Zambon; Jacqueline M Katz
Confronting the avian influenza threat: vaccine development for a potential pandemic.
The Lancet infectious diseases 2004;4(8):499-509.
2004: Iain Stephenson; J M Wood; Karl G Nicholson; A Charlett; Maria C Zambon
Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine.
Virus research 2004;103(1-2):91-5.
2004: Raouf Moussa; Iain Stephenson; Peter Fisk; Jyoti Dhar; Karl G Nicholson; Martin J Wiselka
Buschke-Loewenstein lesion: another possible manifestation of immune restoration inflammatory syndrome?
AIDS (London, England) 2004;18(8):1221-3.
2004: Hoang Thu Vu; Katrin C Leitmeyer; Dang Ha Le; Megge J Miller; Quang Hien Nguyen; Timothy M Uyeki; Mary G Reynolds; Jesper Aagesen; Karl G Nicholson; Quang Huy Vu; Huy Ahn Bach; Aileen J Plan
Clinical description of a completed outbreak of SARS in Vietnam, February-May 2003.
Emerging infectious diseases 2004;10(2):334-8.
2003: Iain Stephenson; Karl G Nicholson; Reinhardt Glück; Robert Mischler; Robert W Newman; Abraham M Palache; Neville Q Verlander; Fiona Warburton; John M Wood; Maria C Zambon
Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial.
Lancet 2003;362(9400):1959-66.
2003: Karl G Nicholson; John M Wood; Maria Zambon
Influenza.
Lancet 2003;362(9397):1733-45.
2003: Karl G Nicholson; Teresa McNally; Michael Silverman; Paul Simons; Maria C Zambon
Influenza-related hospitalizations among young children in Leicestershire.
The Pediatric infectious disease journal 2003;22(10 Suppl):S228-30.
2003: Iain Stephenson; J M Wood; Karl G Nicholson; Maria C Zambon
Sialic acid receptor specificity on erythrocytes affects detection of antibody to avian influenza haemagglutinin.
Journal of medical virology 2003;70(3):391-8.
2003: Nicola J Cooper; Alex J Sutton; Keith Abrams; Allan Wailoo; David Turner; Karl G Nicholson
Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials.
BMJ (Clinical research ed.) 2003;326(7401):1235.
2003: Iain Stephenson; John Roper; Maria Fraser; Karl G Nicholson; Martin Wiselka
Dengue fever in febrile returning travellers to a UK regional infectious diseases unit.
Travel medicine and infectious disease 2003;1(2):89-93.
2003: Iain Stephenson; Karl G Nicholson; Anthony Colegate; Audino Podda; John Wood; Ellen Ypma; Maria Zambon
Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human population.
Vaccine 2003;21(15):1687-93.
2003: Maria Zambon; Karl G Nicholson
Sudden acute respiratory syndrome.
BMJ (Clinical research ed.) 2003;326(7391):669-70.
2003: David Turner; Allan Wailoo; Karl G Nicholson; Nicola Cooper; Alex Sutton; Keith Abrams
Systematic review and economic decision modelling for the prevention and treatment of influenza A and B.
Health technology assessment (Winchester, England) 2003;7(35):iii-iv, xi-xiii, 1-170.
2002: John M Wood; Karl G Nicholson; Iain Stephenson; Maria Zambon; Robert W Newman; Diane Major; Audino Podda
Experience with the clinical development of influenza vaccines for potential pandemics.
Medical microbiology and immunology 2002;191(3-4):197-201.
2002: Iain Stephenson; J P Roper; Karl G Nicholson
Healthcare workers and their attitudes to influenza vaccination.
Communicable disease and public health / PHLS 2002;5(3):247-52.
2001: Karl G Nicholson; Anthony Colegate; Audino Podda; Iain Stephenson; J Wood; Ellen Ypma; Maria C Zambon
Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.
Lancet 2001;357(9272):1937-43.
2001: Iain Stephenson; Karl G Nicholson
Influenza: vaccination and treatment.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2001;17(6):1282-93.
2001: Andrew Smith; Karl G Nicholson
Psychosocial factors, respiratory viruses and exacerbation of asthma.
Psychoneuroendocrinology 2001;26(4):411-20.
2000: Karl G Nicholson; Fred Y Aoki; A D Osterhaus; S Trottier; O Carewicz; C H Mercier; A Rode; N Kinnersley; P Ward
Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.
Lancet 2000;355(9218):1845-50.
2000: Karl G Nicholson
Should staff in long-stay hospitals for elderly patients be vaccinated against influenza?
Lancet 2000;355(9198):83-4.
1999: Martin Wiselka; Karl G Nicholson; S Rowley; Kim Bibby
Cytomegalovirus viraemia has poor predictive value for the development of cytomegalovirus disease in patients with advanced HIV-infection.
The Journal of infection 1999;39(3):187-92.
1999: Karl G Nicholson; J Kent; VS Hammersley
Influenza A among community-dwelling elderly persons in Leicestershire during winter 1993-4; cigarette smoking as a risk factor and the efficacy of influenza vaccination.
Epidemiology and infection 1999;123(1):103-8.
1999: Iain Stephenson; Karl G Nicholson
Chemotherapeutic control of influenza.
The Journal of antimicrobial chemotherapy 1999;44(1):6-10.
1999: Iain Stephenson; Karl G Nicholson
Influenza vaccination and asthma: current studies and recommendations.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 1999;11(4):223-8.
1999: Karl G Nicholson
Workshop. 2: The needs of policy-makers.
PharmacoEconomics 1999;16 Suppl 1():94-6.
1998: Andrew Smith; M Thomas; J Kent; Karl G Nicholson
Effects of the common cold on mood and performance.
Psychoneuroendocrinology 1998;23(7):733-9.
1998: P Shirtcliffe; E Cameron; Karl G Nicholson; Martin Wiselka
Don't forget dengue! Clinical features of dengue fever in returning travellers.
Journal of the Royal College of Physicians of London 1998;32(3):235-7.
1998: Kim Bibby; AR Rosenthal; Karl G Nicholson; Martin Wiselka
Once weekly ganciclovir as prophylaxis is unacceptable to patients.
Sexually transmitted infections 1998;74(2):160-1.
1998: Karl G Nicholson; Jonathan Nguyen Van-Tam; AH Ahmed; Martin Wiselka; J Leese; J Ayres; J H Campbell; P Ebden; N M Eiser; B J Hutchcroft; James C G Pearson; R F Willey; R J Wolstenholme; M A Woodhead
Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma.
Lancet 1998;351(9099):326-31.
1997: A J Colquhoun; Karl G Nicholson; JL Botha; Neil T Raymond
Effectiveness of influenza vaccine in reducing hospital admissions in people with diabetes.
Epidemiology and infection 1997;119(3):335-41.
1997: Karl G Nicholson; J Kent; VS Hammersley; E Cancio
Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden.
BMJ (Clinical research ed.) 1997;315(7115):1060-4.
1997: Frederick G Hayden; A D Osterhaus; John Treanor; DM Fleming; Fred Y Aoki; Karl G Nicholson; Arthur Bohnen; H M Hirst; ON Keene; K Wightman
Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.
The New England journal of medicine 1997;337(13):874-80.
1997: Martin Wiselka; Karl G Nicholson
Outpatient parenteral antimicrobial therapy: experience in a large teaching hospital.
The Journal of infection 1997;35(1):73-6.
1997: AH Ahmed; Karl G Nicholson; VS Hammersley; J Kent
Influenza vaccination in patients with asthma: effect on peak expiratory flow, asthma symptoms and use of medication.
Vaccine 1997;15(9):1008-9.
1997: JM Watson; J F Cordier; Karl G Nicholson
Does influenza immunisation cause exacerbations of chronic airflow obstruction or asthma?
Thorax 1997;52(2):190-4.
1997: AH Ahmed; Karl G Nicholson; Jonathan Nguyen Van-Tam; James C G Pearson
Effectiveness of influenza vaccine in reducing hospital admissions during the 1989-90 epidemic.
Epidemiology and infection 1997;118(1):27-33.
1996: Karl G Nicholson; J Kent; V Hammersley; E Cancio
Risk factors for lower respiratory complications of rhinovirus infections in elderly people living in the community: prospective cohort study.
BMJ (Clinical research ed.) 1996;313(7065):1119-23.
1996: J Collinson; Karl G Nicholson; E Cancio; J Ashman; D C Ireland; V Hammersley; J Kent; Christopher O'Callaghan
Effects of upper respiratory tract infections in patients with cystic fibrosis.
Thorax 1996;51(11):1115-22.
1996: A H Ahmed; Karl G Nicholson
Delays and diversity in the practice of local research ethics committees.
Journal of medical ethics 1996;22(5):263-6.
1996: D C Ireland; Karl G Nicholson
Diagnosis of respiratory virus infections using GACELISA of urinary antibodies.
Journal of immunological methods 1996;195(1-2):73-80.
1996: Karl G Nicholson
Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990.
Epidemiology and infection 1996;116(1):51-63.
1996: A H Ahmed; Karl G Nicholson; V S Hammersley
The contribution of respiratory viruses to severe exacerbations of asthma in adults.
Chest 1996;109(2):588.
1996: Karl G Nicholson
Socioeconomics of influenza and influenza vaccination in Europe.
PharmacoEconomics 1996;9 Suppl 3():75-8.
1996: Karl G Nicholson
Use of antivirals in influenza in the elderly: prophylaxis and therapy.
Gerontology 1996;42(5):280-9.
1995: A E Ahmed; Karl G Nicholson; Jonathan Nguyen Van-Tam
Reduction in mortality associated with influenza vaccine during 1989-90 epidemic.
Lancet 1995;346(8975):591-5.
1995: Karl G Nicholson; R Snacken; A M Palache
Influenza immunization policies in Europe and the United States.
Vaccine 1995;13(4):365-9.
1994: A H Claydon; Karl G Nicholson; Martin Wiselka; R K Firmin
Varicella pneumonitis: a role for extra-corporeal membrane oxygenation?
The Journal of infection 1994;28(1):65-7.
1993: Karl G Nicholson; A H Ahmed
Rapid immune response to influenza vaccination.
Lancet 1993;342(8885):1494-5.
1993: Karl G Nicholson; J Kent; D C Ireland
Respiratory viruses and exacerbations of asthma in adults.
BMJ (Clinical research ed.) 1993;307(6910):982-6.
1993: Jonathan Nguyen Van-Tam; Karl G Nicholson
Influenza immunization; vaccine offer, request and uptake in high-risk patients during the 1991/2 season.
Epidemiology and infection 1993;111(2):347-55.
1993: Martin Wiselka; J Kent; J B Cookson; Karl G Nicholson
Impact of respiratory virus infection in patients with chronic chest disease.
Epidemiology and infection 1993;111(2):337-46.
1993: D C Ireland; J Kent; Karl G Nicholson
Improved detection of rhinoviruses in nasal and throat swabs by seminested RT-PCR.
Journal of medical virology 1993;40(2):96-101.
1993: Karl G Nicholson
Immunisation against influenza among people aged over 65 living at home in Leicestershire during winter 1991-2.
BMJ (Clinical research ed.) 1993;306(6883):974-6.
1993: A P Smith; M Thomas; P Brockman; J Kent; Karl G Nicholson
Effect of influenza B virus infection on human performance.
BMJ (Clinical research ed.) 1993;306(6880):760-1.
1993: Martin Wiselka; Karl G Nicholson
Schistosomiasis in Leicester.
The Journal of infection 1993;26(2):177-9.
1993: Jonathan Nguyen Van-Tam; Karl G Nicholson
Influenza immunisation: policies and practices of general practitioners in England, 1991/92.
Health trends 1993;25(3):101-5.
1992: Jonathan Nguyen Van-Tam; Karl G Nicholson
Influenza deaths in Leicestershire during the 1989-90 epidemic: implications for prevention.
Epidemiology and infection 1992;108(3):537-45.
1992: Karl G Nicholson; D J Baker; P Chakraverty; A Farquhar; D Hurd; J Kent; P A Litton; S H Smith
Immunogenicity of inactivated influenza vaccine in residential homes for elderly people.
Age and ageing 1992;21(3):182-8.
1992: J Schmid; F C Odds; Martin Wiselka; Karl G Nicholson; David Soll
Genetic similarity and maintenance of Candida albicans strains from a group of AIDS patients, demonstrated by DNA fingerprinting.
Journal of clinical microbiology 1992;30(4):935-41.
1992: M B Prentice; A J Flower; G M Morgan; Karl G Nicholson; B Rana; R K Firmin; C J Mitchell
Infection with hepatitis B virus after open heart surgery.
BMJ (Clinical research ed.) 1992;304(6829):761-4.
1992: Karl G Nicholson
Clinical features of influenza.
Seminars in respiratory infections 1992;7(1):26-37.
1992: Martin Wiselka; J Kent; Karl G Nicholson; M Stern
Influenza and asthma.
Lancet 1992;339(8789):367-8.
1991: Martin Wiselka; Karl G Nicholson; J Kent; J B Cookson; D A Tyrrell
Prophylactic intranasal alpha 2 interferon and viral exacerbations of chronic respiratory disease.
Thorax 1991;46(10):706-11.
1991: L A Brown; M Wiselka; A Campbell; James Pringle; Karl G Nicholson; I Lauder
High-grade T-cell lymphoma following treatment with cyclosporin A.
Histopathology 1991;19(3):225-9.
1991: Karl G Nicholson; Martin Wiselka
Amantadine for influenza A.
BMJ (Clinical research ed.) 1991;302(6774):425-6.
1990: Karl G Nicholson; D J Baker; A Farquhar; D Hurd; J Kent; S H Smith
Acute upper respiratory tract viral illness and influenza immunization in homes for the elderly.
Epidemiology and infection 1990;105(3):609-18.
1990: Karl G Nicholson
Influenza vaccination and the elderly.
BMJ (Clinical research ed.) 1990;301(6753):617-8.
1990: A Jane Dickinson; AR Rosenthal; Karl G Nicholson
Inflammation of the retinal pigment epithelium: a unique presentation of ocular schistosomiasis.
The British journal of ophthalmology 1990;74(7):440-2.
1990: Karl G Nicholson
Modern vaccines. Rabies.
Lancet 1990;335(8699):1201-5.
1990: Martin Wiselka; J Kent; Karl G Nicholson
Malaria in Leicester 1983-1988: a review of 114 cases.
The Journal of infection 1990;20(2):103-10.
1990: D A Tyrrell; Karl G Nicholson
Rabies in Britain.
BMJ (Clinical research ed.) 1990;300(6718):137-8.
1989: S P Kelly; AR Rosenthal; Karl G Nicholson; C G Woodward
Retinochoroiditis in acute Epstein-Barr virus infection.
The British journal of ophthalmology 1989;73(12):1002-3.
1989: MARY WARRELL; Nicholas J White; Sornchai Looareesuwan; R E Phillips; Pravan Suntharasamai; Pornthep Chanthavanich; Mario Riganti; S P Fisher-Hoch; Karl G Nicholson; Sathaporn Manatsathit
Failure of interferon alfa and tribavirin in rabies encephalitis.
BMJ (Clinical research ed.) 1989;299(6703):830-3.
1989: J J Kurinczuk; Karl G Nicholson
Uptake of influenza vaccination by patients with serious cardiac disease.
BMJ (Clinical research ed.) 1989;299(6695):367.
1989: Karl G Nicholson; Martin Wiselka
Infectious diseases. A review.
Journal of the Royal College of Physicians of London 1989;23(3):147-51.
1989: J H Jonkman; Karl G Nicholson; P R Farrow; M Eckert; G Grasmeijer; B Oosterhuis; O E De Noord; T W Guentert
Effects of alpha-interferon on theophylline pharmacokinetics and metabolism.
British journal of clinical pharmacology 1989;27(6):795-802.
1989: L Coole; Martin Wiselka; Karl G Nicholson
Malaria prophylaxis in travellers from Britain.
The Journal of infection 1989;18(3):209-12.
1988: S C Ward; Martin Wiselka; Karl G Nicholson
Still's disease and myocarditis associated with recent mumps infection.
Postgraduate medical journal 1988;64(755):693-5.
1988: S E Steare; Martin Wiselka; J J Kurinczuk; Karl G Nicholson
Mycoplasma pneumoniae infection associated with Henoch-Schonlein purpura.
The Journal of infection 1988;16(3):305-7.
1987: Karl G Nicholson; Martin Wiselka; A May
Influenza vaccination of the elderly: perceptions and policies of general practitioners and outcome of the 1985-86 immunization programme in Trent, UK.
Vaccine 1987;5(4):302-6.
1987: Karl G Nicholson; P R Farrow; U Bijok; R Barth
Pre-exposure studies with purified chick embryo cell culture rabies vaccine and human diploid cell vaccine: serological and clinical responses in man.
Vaccine 1987;5(3):208-10.
1987: Martin Wiselka; Karl G Nicholson; S C Ward; A J Flower
Acute infection with human immunodeficiency virus associated with facial nerve palsy and neuralgia.
The Journal of infection 1987;15(2):189-90.
1987: Karl G Nicholson; D A Tyrrell; J S Oxford; J Wood; G C Schild; C W Potter; R Jennings; R H Michaels; G Appleyard
Infectivity and reactogenicity of reassortant cold-adapted influenza A/Korea/1/82 vaccines obtained from the USA and USSR.
Bulletin of the World Health Organization 1987;65(3):295-301.
1986: J M Wood; J Mumford; G C Schild; R G Webster; Karl G Nicholson
Single-radial-immunodiffusion potency tests of inactivated influenza vaccines for use in man and animals.
Developments in biological standardization 1986;64():169-77.
1985: Karl G Nicholson
Hepatitis delta infections.
British medical journal (Clinical research ed.) 1985;290(6479):1370-1.
1985: MARY WARRELL; Karl G Nicholson; D A Warrell; Pravan Suntharasamai; Pornthep Chanthavanich; C Viravan; A Sinhaseni; M K Chiewbambroongkiat; X Pouradier-Duteil; C Xueref
Economical multiple-site intradermal immunisation with human diploid-cell-strain vaccine is effective for post-exposure rabies prophylaxis.
Lancet 1985;1(8437):1059-62.
1984: U Bijok; I Vodopija; S Smerdel; P Thongcharoen; Karl G Nicholson; M Dietrich; A Gonzalez de Cosio
Purified chick embryo cell (PCEC) rabies vaccine for human use: clinical trials.
Behring Institute Mitteilungen 1984;(76):155-64.
1984: Karl G Nicholson
Antiviral therapy. Herpes simplex encephalitis, neonatal herpes infections, chronic hepatitis B.
Lancet 1984;2(8405):736-9.
1984: Karl G Nicholson
Antiviral therapy. Varicella-zoster virus infections, herpes labialis and mucocutaneous herpes, and cytomegalovirus infections.
Lancet 1984;2(8404):677-82.
1984: Karl G Nicholson
Antiviral therapy. Respiratory infections, genital herpes, and herpetic keratitis.
Lancet 1984;2(8403):617-21.
1984: Karl G Nicholson
Properties of antiviral agents. 2.
Lancet 1984;2(8402):562-4.
1984: P R Farrow; Karl G Nicholson
Lack of effect of influenza and pneumococcal vaccines on anticoagulation by warfarin.
The Journal of infection 1984;9(2):157-60.
1984: Karl G Nicholson
Properties of antiviral agents. 1.
Lancet 1984;2(8401):503-6.
1984: L J Anderson; Karl G Nicholson; R V Tauxe; W G Winkler
Human rabies in the United States, 1960 to 1979: epidemiology, diagnosis, and prevention.
Annals of internal medicine 1984;100(5):728-35.
1984: MARY WARRELL; Pravan Suntharasamai; Karl G Nicholson; D A Warrell; Pornthep Chanthavanich; C Viravan; A Sinhaseni; R Phanfung; C Xueref; J C Vincent-Falquet
Multi-site intradermal and multi-site subcutaneous rabies vaccination: improved economical regimens.
Lancet 1984;1(8382):874-6.
1983: Karl G Nicholson; D A Tyrrell; C H Howells; G C Schild; J Oxford
Live influenza vaccines.
Lancet 1983;2(8349):564-5.
1983: MARY WARRELL; D A Warrell; Pravan Suntharasamai; C Viravan; A Sinhaseni; D Udomsakdi; R Phanfung; C Xueref; J C Vincent-Falquet; Karl G Nicholson; D Bunnag; T Harinasuta
An economical regimen of human diploid cell strain anti-rabies vaccine for post-exposure prophylaxis.
Lancet 1983;2(8345):301-4.
1983: Karl G Nicholson; M I Burney; S Ali; F T Perkins
Stability of human diploid-cell-strain rabies vaccine at high ambient temperatures.
Lancet 1983;1(8330):916-8.
1982: G S Turner; Karl G Nicholson; D A Tyrrell; F Y Aoki
Evaluation of a human diploid cell strain rabies vaccine: final report of a three year study of pre-exposure immunization.
The Journal of hygiene 1982;89(1):101-10.
1982: Karl G Nicholson; H Prestage
Enzyme-linked immunosorbent assay: a rapid reproducible test for the measurement of rabies antibody.
Journal of medical virology 1982;9(1):43-9.
1982: B M Totterdell; Karl G Nicholson; J MacLeod; I L Chrystie; J E Banatvala
Neonatal rotavirus infection: role of lacteal neutralising alpha1-anti-trypsin and nonimmunoglobulin antiviral activity in protection.
Journal of medical virology 1982;10(1):37-44.
1981: Karl G Nicholson; H Prestage; P J Cole; G S Turner; S P Bauer
Multisite intradermal antirabies vaccination. Immune responses in man and protection of rabbits against death from street virus by postexposure administration of human diploid-cell-strain rabies vaccine.
Lancet 1981;2(8252):915-8.
1981: Karl G Nicholson
Coincident cytomegalovirus infection and toxoplasmosis in an uncompromised host.
British medical journal (Clinical research ed.) 1981;282(6282):2095.
1981: Karl G Nicholson; S P Bauer; P Harrison
Interference induced in GL-V3 monkey kidney cells by rabies virus strains.
The Journal of general virology 1981;53(Pt 2):347-51.
1981: Karl G Nicholson; S P Bauer
Enteric inoculation with ERA rabies virus: evaluation of a candidate wildlife vaccine in laboratory rodents.
Archives of virology 1981;67(1):51-6.
1979: Karl G Nicholson; P J Cole; G S Turner; P Harrison
Immune responses of humans to a human diploid cell strain of rabies virus vaccine: lymphocyte transformation, production of virus-neutralizing antibody, and induction of interferon.
The Journal of infectious diseases 1979;140(2):176-82.
1979: Karl G Nicholson; P Harrison; G S Turner
Rabies neutralizing antibody determination by the interference inhibition test (IIT) and the mouse neutralization test (MNT).
Journal of biological standardization 1979;7(3):253-61.
1979: Karl G Nicholson; D A Tyrrell; P Harrison; C W Potter; R Jennings; A Clark; G C Schild; J M Wood; R Yetts; V Seagroatt; A Huggins; S G Anderson
Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions.
Journal of biological standardization 1979;7(2):123-36.
1979: Karl G Nicholson; E K Kuwert; J Werner; P Harrison
Interferon response to human diploid cell strain rabies vaccines in man.
Archives of virology 1979;61(1-2):35-9.
1978: C W Potter; R Jennings; Karl G Nicholson
Immunity to influenza virus infection induced by heterologous, inactivated vaccines.
Medical microbiology and immunology 1978;166(1-4):99-108.
1978: Karl G Nicholson; G S Turner; F Y Aoki
Immunization with a human diploid cell strain of rabies virus vaccine: two-year results.
The Journal of infectious diseases 1978;137(6):783-8.
1978: Karl G Nicholson; G S Turner
Studies with human diploid cell strain rabies vaccine and human antirabies immunoglobulin in man.
Developments in biological standardization 1978;40():115-20.
1977: C W Potter; R Jennings; Karl G Nicholson; D A Tyrrell; K G Dickinson
Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines.
The Journal of hygiene 1977;79(3):321-32.
1977: Karl G Nicholson; C V Lawford; D A Tyrrell
Studies of respiratory function in volunteers given live influenza virus vaccine.
Developments in biological standardization 1977;39():129-34.
1976: G S Turner; F Y Aoki; Karl G Nicholson; D A Tyrrell; L E Hill
Human diploid cell strain rabies vaccine. Rapid prophylactic immunisation of volunteers with small doses.
Lancet 1976;1(7974):1379-81.
1976: Karl G Nicholson; D A Tyrrell; D S Freestone
WRL 105 strain (H3N2) live attenuated influenza vaccine: acceptability, reactivity, and antibody response in normal, bronchitic, and geriatric volunteers.
Lancet 1976;1(7973):1309-11.